Association of interleukin-6 gene -572 C > G polymorphism with dietary intake of n-3 fatty acids on plasma HDL-c level in Chinese male adults

Asia Pacific Journal of Clinical Nutrition

Volumn 19, Issue 4, 2010, Pages 506-512

  Zhou, Quan ^a   Zhang, Bo ^a   Wang, Ping ^a   Mei, Fang ^a   Chen, Chao Gang ^a   Sun, Li na ^a   Xu, Ying ^a   Su, Yi xiang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

HDL c; Interaction; Interleukin 6; N 3 polyunsaturated fatty acids; Polymorphism

Indexed keywords

BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; OMEGA 3 FATTY ACID;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; CHINA; CROSS-SECTIONAL STUDY; DIET; FEMALE; GENETIC POLYMORPHISM; GENETICS; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; POLYMERASE CHAIN REACTION; SEX RATIO;

ADULT; AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CHINA; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; DIET; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SEX DISTRIBUTION;

EID: 78751557789     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;340:115-26.
2. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med. 1998;128:127-37.
3. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis. 2000;148:209-14.
4. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myo-cardial infarction among apparently healthy men. Circulation. 2000;101:1767-72.
5. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000; 342:836-43.
6. Hardardottir I, Gruenfeld C, Feingold KR. Effects of en-dotoxin and cytokines on lipid metabolism. Curr Opin Lipi-dol. 1994;5:207-15.
7. Esteve E, Ricart W, Fernandez-Real JM. Dyslipidemia and inflammation: an evotutionary conserved mechanism. Clin Nutr. 2005;24:16-31.
8. Mendall MA, Patel P, Asante M, Ballam L, Morris J, Strachan DP, Camm AJ, Northfield TC. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart. 1997;78:273-7.
9. Zuliani G, Volpato S, Ble A, Bandinelli S, Corsi AM, Lauretani F, Paolisso G, Fellin R, Ferrucci L. High inter-leukin-6 plasma levels are associated with low HDL-C levels in community-dwelling older adults: the InChianti study. Atherosclerosis. 2007;192:384-90.
10. Worns MA, Victor A, Galle PR, Hohler T. Genetic and environmental contributions to plasma C-reactive protein and interleukin-6 levels-a study in twins. Genes Immun. 2006;7:600-5.
11. Bennermo M, Held C, Green F, Strandberg LE, Ericsson CG, Hansson LO, Watkins H, Hamsten A, Tornvall P. Prognostic value of plasma interleukin-6 concentrations and the -174 G > C and -572 G > C promoter polymorphisms of the interleukin-6 gene in patients with acute myocardial infarction treated with thrombolysis. Atherosclerosis. 2004; 174:157-63.
12. Malarstig A, Wallentin L, Siegbahn A. Genetic variation in the interleukin-6 gene in relation to risk and outcomes in acute coronary syndrome. Thromb Res. 2007;119:467-73.
13. Sing CF, Stengard JH, Kardia SL. Genes, environment, and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2003;23:1190-6.
14. Fontaine-Bisson B, Wolever TMS, Chiasson JL, Rabasa-Lhoret R, Maheux P, Josse RG, et al. Genetic polymorphisms of tumor necrosis factor-alpha modify the association between dietary polyunsaturated fatty acids and fasting HDL-cholesterol and apo A-I concentrations. Am J Clin Nutr. 2007;86:768-74.
15. Corella D, Ordovas JM. Single nucleotide polymorphisms that influence lipid metabolism: Interaction with dietary factors. Annu Rev Nutr. 2005;25:341-90.
16. Farquhar JW, Ahrens EH, Jr. Effects of dietary fats on human erythrocyte fatty acid patterns. J Clin Invest. 1963; 42:675-85.
17. Fuhrman BJ, Barba M, Krogh V, Micheli A, Pala V, Lauria R, et al. Erythrocyte membrane phospholipid composition as a biomarker of dietary fat. Ann Nutr Metab. 2006;50:95-102.
18. Zhang B, Wang P, Chen CG, He QQ, Zhuo SY, Chen YM, Su YX. Validation of an FFQ to estimate the intake of fatty acids using erythrocyte membrane fatty acids and multiple 3d dietary records. Public Health Nutr. 2009;13:1546-52.
19. McNamara DT, Thomson JM, Kasehagen LJ, Zimmerman PA. Development of a multiplex PCR-ligase detection reaction assay for diagnosis of infection by the four parasite species causing malaria in humans. J Clin Microbiol. 2004; 42:2403-10.
20. Brull DJ, Montgomery HE, Sanders J, Dhamrait S, Luong L, Rumley A, Lowe GD, Humphries SE. Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol. 2001; 21:1458-63.
21. Ferrari SL, Ahn-Luong L, Garnero P, Humphries SE, Greenspan SL. Two promoter polymorphisms regulating in-terleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. J Clin Endocrinol Metab. 2003; 88:255-9.
22. Marx N, Duez H, Fruchart JC, Staels B. Peroxisome prolif-erator-activated receptors and atherogenesis: regulators of gene expression in vascular cells. Circ Res. 2004;94:1168-78.
23. Sampath H, Ntambi JM. Polyunsaturated fatty acid regulation of genes of lipid metabolism. Annu Rev Nutr. 2005; 25:317-40.
24. Chew CH, Chew GS, Najimudin N, Tengku-Muhammad TS. Interleukin-6 inhibits human peroxisome proliferator activated receptor alpha gene expression via CCAAT/enhancer-binding proteins in hepatocytes. Int J Biochem Cell Biol. 2007;39:1975-86.
25. Childs CE, Romeu-Nadal M, Burdge GC, Calder PC. Gender differences in the n-3 fatty acid content of tissues. Proc Nutr Soc. 2008;67:19-27.
26. Assmann G, Schulte H. Relation of high-density-lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary-artery disease (The Procam Experience). Am J Cardiol. 1992;70:733-7.
27. Brown BG, Stukovsky KH, Zhao XQ. Simultaneous low-density lipoprotein-C lowering and high-density lipoprotein-C elevation for optimum cardiovascular disease prevention with various drug classes, and their combinations: a meta-analysis of 23 randomized lipid trials. Curr Opin Lipidol. 2006;17:631-6.
28. Assmann G, Gotto AM. HDL cholesterol and protective factors in atherosclerosis. Circulation. 2004;109:8-14.